Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo

Risk Evaluation and Mitigation Strategies (REMS) and Generic Drugs (CRS Report for Congress)

Premium   Purchase PDF for $24.95 (3 pages)
add to cart or subscribe for unlimited access
Release Date Oct. 31, 2016
Report Number IF10494
Report Type In Focus
Authors Agata Dabrowska
Source Agency Congressional Research Service